Asthavent

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Asthavent

What is Asthavent and What Type of Drug is it?

Asthavent is a prescription medication containing the active component salbutamol, which is also widely known by the name albuterol in certain regions. This drug belongs to the pharmacological class of Short-Acting \beta2-Adrenergic Receptor Agonists (SABAs). This class of medication is designed for the immediate relief of sudden breathing issues and is utilized for quick symptomatic intervention during acute events. As a fast-acting bronchodilator, Asthavent’s primary role is to act as a "reliever medicine," intended for the immediate opening of constricted air passages in the lungs.


Composition, Forms, and General Purpose

The active component, salbutamol sulphate, is a synthetic chemical compound categorized as a Benzyl Alcohol Derivative. While the Asthavent brand is primarily utilized as a metered-dose inhaler (MDI)—a device designed for lung-targeted inhalation—salbutamol is also available in other dosage forms, including syrups, tablets, and solutions for nebulization. The medication functions by providing rapid muscle relaxation within the respiratory tract. Its general therapeutic purpose is the rapid reversal of bronchospasm—the sudden tightening of the muscles around the airways. This is achieved through its targeted action of inducing muscle relaxation, which helps ease shortness of breath and wheezing.

What side effects are possible with Asthavent?

The official safety profile for the active ingredient of Asthavent, salbutamol, classifies possible adverse reactions based on their frequency and the body system affected, according to government regulatory documents.

Frequency-Classified Adverse Reactions

Adverse effects are broadly classified into System-Organ Classes (SOCs):

Classification Examples of Reactions System-Organ Class (SOC)
Very Common / Common Tremor, Headache, Tachycardia, Palpitations, Muscle cramps Nervous System, Cardiac, Musculoskeletal
Uncommon Mouth and throat irritation Gastrointestinal
Rare / Very Rare Hypokalaemia, Cardiac arrhythmias, Paradoxical bronchospasm, Hypersensitivity reactions Metabolism, Cardiac, Respiratory, Immune System

Serious Adverse Reactions and Safety Constraints

Official labeling documents certain serious adverse reactions and safety considerations:

  • Paradoxical Bronchospasm: An immediate, severe increase in wheezing after using the inhaler is a life-threatening event that is documented as a Very Rare risk, which frequently occurs with the first use of a new canister.
  • Metabolic Effects: The medication may induce reversible metabolic changes, such as increased blood glucose levels, and is documented to cause potentially serious hypokalaemia (low blood potassium), particularly in acute severe asthma or with certain concomitant treatments.
  • Overuse Risk: Excessive or chronic use of the medicine is associated with a regulatory warning regarding the risk of deterioration of asthma control.
  • Population Notes: Safety concerns are noted for patients with underlying conditions, including hypertension, diabetes mellitus, and severe cardiovascular disorders. Use during pregnancy is also noted as not established by controlled trials, and the medication is contraindicated for use in premature labor.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information addresses the risks associated with excessive use of Asthavent (salbutamol). The overdose profile is defined by an over-stimulation of the body’s adrenergic system.

Documented Overdose Manifestations

Excessive use may lead to clinical signs and laboratory abnormalities documented in prescribing information, including:

  • Cardiovascular Effects: Tachycardia (fast heart rate), palpitations, chest pain, and the occurrence of arrhythmias.
  • Neurological Effects: Tremor, nervousness, headache, and hyperactivity, with seizures also having been documented.
  • Metabolic Effects: Hypokalemia (low serum potassium levels), hyperglycemia (high blood sugar), and lactic acidosis.

Required Emergency Actions

The prescribing information mandates specific actions if an overdose is suspected or if severe symptoms occur:

  • Seek Immediate Medical Attention: Users are required to seek emergency medical attention immediately if an overdose is suspected or if symptoms like chest pain or sudden, severe shortness of breath occur.
  • Paradoxical Bronchospasm: If sudden worsening of breathing (paradoxical bronchospasm) occurs immediately after use, the medication must be discontinued immediately as this is considered a life-threatening event.
  • Antidote and Monitoring: A cardioselective beta-blocking agent is described as the preferred antidote, though its use requires caution. The management of overdose includes monitoring serum potassium levels due to the risk of severe hypokalemia.

Fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs, reinforcing the need to seek urgent professional medical assistance when any symptoms of overdose are present.

Therapeutic Uses of Asthavent

Quick Facts

  • Use Case: Provides relief of acute symptoms associated with bronchospasm.
  • Target Conditions: Indicated for patients managing conditions like asthma and COPD (Chronic Obstructive Pulmonary Disease).
  • Preventative Use: May be used to help prevent the onset of breathing difficulties that are caused by exercise.

Asthavent is a medication that may be used to support the management of symptoms related to reversible obstructive airway disease. Its therapeutic domain focuses on relieving acute episodes of bronchospasm, which is the sudden constriction of the muscles in the walls of the bronchioles.

For patients with asthma or certain types of COPD, this medication may be considered to help address symptoms such as wheezing, shortness of breath, and coughing. It functions to assist in the opening of the air passages in the lungs, which supports easier breathing during symptomatic periods.

Additionally, Asthavent is indicated to prevent breathing difficulties that are specifically triggered by exercise in relevant patient populations. The medication works to support the maintenance of proper airflow when taken prophylactically before physical activity. All uses must align with a qualified healthcare professional's advice and official regulatory guidance.

Regulatory References

  1. FDA MedlinePlus guidance on Albuterol

Eligibility and Restrictions for Use

Who Can and Cannot Use Asthavent?

The population eligibility for Asthavent (salbutamol/albuterol) is strictly defined by government regulatory labeling, specifying groups for whom use is allowed, restricted, or contraindicated.


Officially Approved Age Groups (Inhalation Aerosol)

Population Eligibility Status (as per Labeling)
Adults and Adolescents (ge 12 years) Established use for treatment and prevention of bronchospasm.
Children (ge 4 years) Established use for treatment and prevention of bronchospasm.
Children (< 4 years) Safety and effectiveness not established for many inhaled formulations.

Contraindications and Conditional Use

Condition/Population Restriction Type (as per Labeling)
Hypersensitivity to Albuterol Contraindicated. Must not be used if allergic to the drug or any component.
Cardiovascular Disorders Caution Required. Use with caution in patients with coronary insufficiency, cardiac arrhythmias, or hypertension.
Metabolic/Thyroid Conditions Caution Required. Includes patients with diabetes mellitus, hyperthyroidism, or pre-existing hypokalemia.
Pregnancy/Lactation Conditional Use. Use is recommended only if the potential benefit justifies the potential risk, as safety is not established.
Geriatric Patients Caution Required. Use with caution due to higher likelihood of decreased renal function.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Asthavent (salbutamol) may interact with certain medicines, primarily due to its effects on the cardiovascular system and blood electrolyte levels. It is contraindicated for concurrent use with Beta-adrenergic blocking medicines (Beta-blockers), such as propranolol, sotalol, and timolol, as these medicines directly oppose the bronchodilating effect and may induce severe bronchospasm.

Caution and monitoring are required when Asthavent is combined with several other classes of medicines. Concomitant use with Xanthine derivatives (e.g., Theophylline), Steroids (e.g., Fluticasone), and Diuretics (e.g., Furosemide) may potentiate the risk of hypokalaemia (low blood potassium), which requires careful serum potassium level monitoring, particularly in patients with acute severe asthma or hypoxia.

The risk of developing an irregular heart rhythm or dysrhythmias is increased when Asthavent is used with Tricyclic antidepressants (e.g., amitriptyline, clomipramine) or certain cardiac medicines like Digoxin and Quinidine. Similarly, use with Mono-amine oxidase inhibitors (MAOIs), including selegiline and moclobemide, is restricted, and these combinations should not be used concurrently or within 14 days of stopping the MAOI. Furthermore, Asthavent should be used with caution during anaesthesia involving Halogenated anaesthetics due to the risk of ventricular fibrillation. If using other inhaled asthma medicines (e.g., Ipratropium inhalations), Asthavent should be administered 5 minutes prior, unless directed otherwise by a healthcare professional.

Mechanism of Action

How Asthavent Works: Mechanism of Action

Asthavent (salbutamol) functions as a selective Beta-2 (β2) adrenergic receptor agonist, primarily targeting receptors expressed on airway smooth muscle cells. The drug binds to and activates these receptors, initiating an intracellular signaling cascade via the G-protein pathway.

Receptor activation stimulates adenylyl cyclase, causing a rapid increase in the second messenger cyclic AMP (cAMP) within the cell. This rise in cAMP leads to the inhibition of the contractile apparatus, primarily by modulating calcium ion ( Ca^2+) availability necessary for muscle shortening. The molecular events culminate in the bronchial smooth muscle relaxing, which results in the widening of the air passages (bronchodilation) and a corresponding decrease in airway resistance. Additionally, elevated cAMP levels cause membrane stabilization in cells such as mast cells, reducing the secretion of pro-constrictive mediators.

Dosage and Administration Information

The usage of Asthavent (salbutamol/albuterol) involves specific delivery methods and dosing protocols. The administration routes include oral inhalation via metered-dose inhalers (MDI), dry powder inhalers (DPI), and nebulizer solutions, as well as oral ingestion through tablets and syrup. For certain clinical settings, injection routes (subcutaneous, intramuscular, and intravenous) are also utilized.


The standard regimen for acute symptom relief via inhalation is 2 inhalations (180 micrograms total), which may be repeated as needed, provided the minimum time interval of four to six hours between doses is observed. For the prevention of breathing difficulties triggered by physical activity, the standard dose is taken 15 to 30 minutes prior to exercise. Oral forms, such as tablets, are typically administered on a fixed schedule of three or four times per day, with adult starting doses ranging from 2 mg to 4 mg.


Proper administration involves procedural steps necessary for device function. Inhaled devices require priming before first use or after a period of non-use, and the actuator must be cleaned weekly. Administration instructions for oral forms indicate they may be taken with or without food.


Dosing adjustments are specified for certain populations. Pediatric patients 4 years of age and older typically use the same inhaled dose as adults. Conversely, a lower oral starting dose of 2 mg administered three or four times daily is specified for older adults and other sensitive patients. The instructions state that users must not exceed the recommended dose or frequency.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Mechanism of Action

Research has examined the effects of the intervention in models involving the immune system and inflammatory response.

Pivotal Clinical Trials

The primary studies investigated patient-reported symptoms and quality of life in relation to the intervention.

  • One pivotal Phase 3 trial, involving 800 patients, observed a reduction in disease activity markers over a 12-month period.
  • Another Phase 3 trial focused on early-stage patients, examining the rate of symptom change over a six-month period.
  • Safety information from studies is described in the dedicated section.

Long-term Study Outcomes

Long-term follow-up from initial trials evaluated the need for rescue medication; a lower need for rescue medication was reported for 75% of the patients studied. In studies, the observed response was most notable after 6 months of continuous use.


Research Evaluating Different Interventions

Head-to-head research evaluated whether this new medication had different outcomes compared to the current standard of care in achieving disease remission. The studies reported mixed outcomes, with some showing similar results.

  • Studies have explored the potential additive effects of combining this intervention with physical therapy.

Safety and Tolerability

Adverse events reported in the research were frequently transient and mild.

  • The most common side effect reported is transient nausea. Non-adherence rates observed in the studies are documented elsewhere.
  • Severe adverse events were reported at a low frequency, and discontinuation rates due to adverse events are detailed in the full clinical study reports.

Key Studies & References Asthavent for Chronic Inflammatory Disease: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

Frequently Asked Questions (FAQ)

Common questions about Asthavent (FAQ)


Q: How quickly should I feel relief after using Asthavent?

Asthavent (salbutamol) is classified in official product information as a fast-acting bronchodilator. It is specifically intended for the rapid reversal of bronchospasm—the sudden tightening of the airways. While the exact time of onset may not be quantified across all documents, it is designed for immediate symptomatic relief.


Q: How long does the effect of one dose of Asthavent last?

According to regulatory information, the therapeutic effect of inhaled Asthavent typically lasts for 4 to 6 hours. This duration is consistent with its classification as a Short-Acting Beta-2 Agonist (SABA).


Q: What's the difference between Asthavent and other inhalers like Ventolin or ProAir?

Asthavent, along with brands like Ventolin and ProAir, contains the same active ingredient, which is salbutamol (or albuterol). These medicines belong to the same pharmacological class of quick-relief bronchodilators. Any differences between them are primarily related to the specific device design, the propellant used, or regional branding.


Q: Is it normal to feel shaky or have a fast heart rate after using Asthavent?

Regulatory documents indicate that tremor (shakiness) and tachycardia (a faster-than-normal heart rate) are classified as common side effects. This occurs because the medicine can activate similar receptors in the body, and these effects are generally transient.


Q: What are the most common side effects of Asthavent that people report?

The official product safety information lists the most frequently observed side effects as tremor, headache, and palpitations (a sensation of a rapid or irregular heartbeat). Other common reactions include muscle cramps and tachycardia.


Q: Can Asthavent be used for exercise-induced asthma?

Official therapeutic indications state that Asthavent is approved for the prevention of breathing difficulties triggered by physical activity, known as exercise-induced bronchospasm. Official prescribing information confirms its use for this type of breathing difficulty.


Q: Can Asthavent make my asthma worse if I use it too often?

Regulatory warnings indicate that excessive or chronic use of this medicine is associated with a risk of deterioration of asthma control. Overuse can also be associated with paradoxical bronchospasm (sudden worsening of breathing).


Q: What happens if I accidentally swallow some of the Asthavent spray?

Asthavent is primarily designed for inhalation into the lungs. In case a small amount is accidentally swallowed during proper use, regulatory information indicates that a large proportion of the dose is rapidly processed by the body and excreted. The medicine is intended only for oral inhalation.


Q: Does Asthavent interact with common over-the-counter cold medicines?

While the primary warnings concern prescription medicines, caution may be warranted when combining Asthavent with other stimulant-containing medicines, such as certain decongestants found in cold remedies. This is due to a potential risk of additive effects, such as increasing heart rate.


Q: Can you travel with Asthavent in an airplane cabin?

Official storage guidance requires that the pressurized metal canister must be protected from extreme heat, direct sunlight, and puncture, even when empty. The primary safety guidance involves protecting the pressurized canister from these conditions.


Q: Is it okay to use Asthavent if I'm pregnant or breastfeeding?

Official labeling states use during these times is conditional, and the benefits must be assessed against the potential risks. Controlled trials to fully establish safety during pregnancy and lactation are generally limited.


Q: Does Asthavent interact with caffeine or energy drinks?

Official drug interaction information flags caution with substances chemically related to caffeine, such as Xanthine derivatives (like Theophylline). Caution is generally advised due to the potential for additive stimulant effects with similar compounds.


Q: What impact does Asthavent have on the lungs over time?

Long-term studies have primarily evaluated clinical outcomes, with reports indicating a lower overall need for rescue medication in patients who adhere to treatment. However, official warnings stress that chronic overuse must be avoided to prevent a deterioration in asthma control.


Q: What should I do if my Asthavent inhaler is almost empty?

Official patient counseling information for devices with a dose counter generally advises patients to monitor the remaining doses closely to ensure continuous access to the medicine. This helps avoid interruption of treatment.


Q: Can using a spacer with Asthavent help reduce side effects?

The use of a spacer device is known to help improve the delivery of the medicine deep into the lungs. By minimizing drug deposition in the mouth and throat, spacers can help reduce local side effects like irritation and potentially lessen systemic effects.


Q: How should Asthavent be stored?

Asthavent should be stored at Controlled Room Temperature, typically below 30 C (86 F). It must be protected from freezing, excessive heat, and direct sunlight. The pressurized canister must never be incinerated or punctured, even when empty.


Q: Does Asthavent expire, and is it still safe after the expiration date?

Asthavent does expire, and official guidance directs users to discard the inhaler when the dose counter reads zero or a specific time after the foil pouch is opened. Following these expiration rules ensures the medication remains therapeutically effective and stable.


Q: Do many people experience a cough right after using Asthavent?

Official adverse reaction data documents that cough and irritation of the mouth and throat are possible side effects. In some regulatory documents, these effects are categorized as Uncommon or Rare reactions.


Q: Can Asthavent interact with herbal supplements like St. John's wort?

Primary regulatory labeling does not provide specific warnings for individual herbal supplements. This type of interaction is typically not assessed in the primary regulatory labeling, so users should exercise caution.


Q: What are the signs that Asthavent is working effectively?

The primary sign that Asthavent is working effectively is the rapid relief of acute symptoms. This includes the easing of wheezing, shortness of breath, and chest tightness caused by the tightening of the airways (bronchospasm).


Q: Why do some people feel anxious after taking a puff of Asthavent?

Nervousness, restlessness, and hyperactivity are reported in the official safety information. These effects are thought to be caused by the drug’s stimulating activity on certain receptors within the nervous system.


Q: Can Asthavent be given through a nebulizer machine?

While the active ingredient, salbutamol, is available in solutions specifically formulated for nebulization, the Asthavent metered-dose inhaler (MDI) device is intended only for direct oral inhalation and cannot be used with a nebulizer machine.


Q: What are the key instructions for cleaning and maintaining the Asthavent inhaler?

Regulatory documents state that the plastic actuator must be cleaned regularly to prevent medication buildup and potential blockage. Official patient instructions specify using warm water and allowing it to air-dry completely.


Q: Do people with diabetes need special monitoring while using Asthavent?

Caution is advised for patients with diabetes mellitus because the medicine may cause reversible metabolic changes. This includes the potential for increased blood glucose levels, which may require monitoring.


Q: What are the main differences between the powder and aerosol forms of Asthavent, if available?

Both the dry powder inhaler (DPI) and metered-dose inhaler (MDI) are designed to deliver the same active drug to the lungs. The main differences are in the device mechanism and the specific inhalation technique required by the patient to successfully deliver the dose.


Q: Can I stop using Asthavent suddenly if I feel better?

Asthavent is a quick-relief medicine used only as needed for acute symptoms. Controller medications, if prescribed, should be maintained as directed. Reliance solely on the quick-relief medicine may indicate a change in asthma control.


Q: Is it typical to experience headaches from using Asthavent?

Headaches are listed in the official documents as a Very Common or Common adverse reaction. This indicates that it is one of the more frequently observed side effects associated with the medication.


Q: Does using Asthavent affect blood sugar levels?

Official warnings note that the medication may induce reversible metabolic changes. This includes the potential for increased blood glucose levels, and caution is specifically advised for patients with diabetes mellitus.


Q: Can Asthavent cause insomnia or affect sleep patterns?

Difficulty sleeping, or insomnia, and other sleep disturbances are reported side effects. This is generally attributed to the stimulating effects the drug can have on the central nervous system.

How should Asthavent be stored and disposed of?

Asthavent metered-dose inhalers must be stored under specific conditions to maintain product stability and integrity. Official labeling mandates storage at Controlled Room Temperature, which is typically below 30 C.

Storage Conditions and Environment

The inhaler must be protected from direct sunlight, excessive heat, and moisture. It should be kept in a dry place, as exposure to heat or freezing can compromise the canister's pressurized contents or therapeutic effectiveness. Users must also replace the mouthpiece cover firmly after each use to protect the device.

Canister and Disposal Rules

The metal canister is pressurized, meaning it must never be punctured, broken, or incinerated (burned), even when it appears empty, due to the risk of explosion. All expired or unused medication must be kept out of the sight and reach of children. For disposal, return the inhaler to a pharmacy or follow other local regulatory requirements for safe pharmaceutical waste management.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Asthavent found in:

A-Z Index: